<DOC>
	<DOCNO>NCT02426463</DOCNO>
	<brief_summary>Children differ adult respect growth development also immaturity various pharmacological mechanism . Dosing scheme child usually derive empirical manner clinical trial adult patient group . All pose neonate increase risk therapeutic failure adverse drug reaction . Medicinal product study project among one high need research pediatric intensive care . This project focus necessity integrate subject 's individual characteristic assist clinical decision-making drug therapy . The investigator explore mechanism define dose response pediatric population . The result obtain study help find safe drug dosing regimen delicate patient population .</brief_summary>
	<brief_title>Clinical Trial Individual Characteristics Affecting Pain Drug Therapy Neonates</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Given informed consent guardian eligible patient . Patient 24 week old body weight 500 g. Patient need intensive care treatment base clinical decision neonatologist receive propofol oxycodone therapy . Attending neonatologist make decision prescribe propofol schedule short procedural sedation oxycodone analgesia well treatment related decision . Eligible patient guardian decline give informed consent . A previous history intolerance study drug related compound additive . History kind drug allergy . Participation study concomitantly within one month prior entry study .</criteria>
	<gender>All</gender>
	<minimum_age>24 Weeks</minimum_age>
	<maximum_age>40 Weeks</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Neonatal intensive care</keyword>
	<keyword>need intratracheal intubation</keyword>
</DOC>